Ashley Cooper
Chief Executive Officer at Aramune Technologies Limited- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Aramune Technologies Limited
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
Dec 2020 - 3 years 1 month
Belfast City, Northern Ireland, United Kingdom ATL’s overarching objective is to facilitate a reduction in the routine, systematic overuse of antimicrobials in livestock production systems by harnessing the power of animal and human microbiomes to boost the immune system for maximal therapeutic benefit. To accomplish this objective, ATL is pioneering the extraction and full characterisation of natural plant phytochemicals from the Malvacaea (Mallow) plant family with significant and proven potential to improve the health and performance of… Show more ATL’s overarching objective is to facilitate a reduction in the routine, systematic overuse of antimicrobials in livestock production systems by harnessing the power of animal and human microbiomes to boost the immune system for maximal therapeutic benefit. To accomplish this objective, ATL is pioneering the extraction and full characterisation of natural plant phytochemicals from the Malvacaea (Mallow) plant family with significant and proven potential to improve the health and performance of commercial livestock and companion animals. We have also demonstrated in-vivo that these natural plant compounds are able to restore neuronal function in industry standard models of neurodegenerative disease in humans Show less
-
-
-
Cooper Ventures Limited
-
United Kingdom
-
Retail Office Equipment
-
Managing Director
-
Aug 2007 - 16 years 5 months
Buckinghamshire, United Kingdom I have run my own consultancy, Cooper Ventures Ltd (CVL) since 2007. CVL provides support and advice to emerging biomedical and med-tech companies in areas of commercial and financing strategy, fundraising, business development, management and administration. My specialism is the commercialisation of ex-academic IP and the establishment of University spin out companies, a process in which I have considerable expertise. In various consultancy roles I have raised and or assisted in raising… Show more I have run my own consultancy, Cooper Ventures Ltd (CVL) since 2007. CVL provides support and advice to emerging biomedical and med-tech companies in areas of commercial and financing strategy, fundraising, business development, management and administration. My specialism is the commercialisation of ex-academic IP and the establishment of University spin out companies, a process in which I have considerable expertise. In various consultancy roles I have raised and or assisted in raising significant venture capital, private equity and debt finance and negotiated significant licensing deals and commercial collaborations. My particular specialism I have provide my services as CEO on an interim, part time and full time basis. Show less
-
-
-
-
Chief Executive Officer
-
Jan 2020 - Aug 2023
Brighton, England, United Kingdom
-
-
-
Inventa Therapeutics
-
United Kingdom
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Executive Officer
-
Aug 2019 - Aug 2023
Nottingham, UK
-
-
-
-
CEO
-
Feb 2019 - Mar 2020
Teddington, United Kingdom
-
-
-
-
Managing Director
-
Sep 2018 - Nov 2019
Exeter, United Kingdom
-
-
-
Aston Particle Technologies Ltd.
-
United Kingdom
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
CEO
-
Feb 2018 - Oct 2018
Birmingham, United Kingdom
-
-
-
Pertinax Pharma Limited
-
United Kingdom
-
Medical Equipment Manufacturing
-
CEO
-
Aug 2015 - Nov 2017
Bristol, United Kingdom
-
-
-
Cotton Mouton Diagnostics Limited
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
CEO
-
Sep 2015 - Aug 2017
Cardiff, United Kingdom
-
-
-
Placentum Limited
-
United Kingdom
-
CEO
-
Jul 2016 - Jul 2017
Bristol, United Kingdom
-
-
-
-
CEO
-
Aug 2015 - Apr 2016
Birmingham, United Kingdom
-
-
-
-
CEO
-
Jul 2013 - Sep 2014
Nottingham, United Kingdom Regenerative medicine
-
-
-
Reinnervate Limited
-
United Kingdom
-
Research Services
-
CEO
-
Sep 2007 - Jul 2013
Sedgefield, County Durham, United Kingdom Novel 3D cell culture technology. See video at; https://www.youtube.com/watch?v=NjvfR00_KD4
-
-
-
Novocellus Ltd
-
United Kingdom
-
Research Services
-
Chief Executive Officer
-
2003 - 2006
Guildford, United Kingdom IVF diagnostics
-
-
-
F2G Ltd
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
2000 - 2003
Manchester, United Kingdom Antifungal drug discovery and development
-
-
-
Veterinary Practice Initiatives Ltd
-
United Kingdom
-
Biotechnology
-
Chief Executive Officer
-
Dec 1996 - Dec 1999
Ascot, Berkshire Veterinary practice consolidation and management company
-
-
-
Heska Corporation
-
Canada
-
Accounting
-
1 - 100 Employee
-
VP Sales & Marketing
-
Jan 1995 - Nov 1996
Fort Collins, Colorado Veterinary products
-
-
-
-
Business Development Manager
-
Jan 1993 - Jan 1995
Knutsford, Cheshire Diagnostics
-
-
-
IDEXX Laboratories
-
United Kingdom
-
Veterinary Services
-
100 - 200 Employee
-
UK Country Manager
-
1989 - 1992
Slough, United Kingdom Clinical veterinary, food and environmental diagnostics
-
-